NCT05058495

Brief Summary

The aim of this randomized controlled study is to evaluate the effect of the mobile lymphedema self-care support program on self-care, quality of life and symptoms related to lymphedema in women with breast cancer-related lymphedema. H1: There is a difference between the Lymphedema Self-Care Scale mean score in women who develop lymphedema due to breast cancer, according to the use of the mobile lymphedema self-care support program. H2: There is a difference between the Lymphedema Quality of Life Scale average score in women who develop lymphedema due to breast cancer according to the status of using the mobile lymphedema self-care support program. H4: There is a difference between lymphedema arm circumference measurements according to the use of the mobile lymphedema self-care support program in women who develop lymphedema due to breast cancer. H5: In women who develop lymphedema due to breast cancer, there is a difference in the situation of experiencing symptoms related to lymphedema according to the use of the mobile lymphedema self-care support program.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
98

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 15, 2021

Completed
7 months until next milestone

Study Start

First participant enrolled

September 1, 2021

Completed
26 days until next milestone

First Posted

Study publicly available on registry

September 27, 2021

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2021

Completed
Last Updated

February 20, 2024

Status Verified

February 1, 2024

Enrollment Period

3 months

First QC Date

February 15, 2021

Last Update Submit

February 16, 2024

Conditions

Keywords

self-caremobile applicationquality of lifepatient educationsymptomsBreast Cancer Related Lymphedema

Outcome Measures

Primary Outcomes (3)

  • Change in Breast Cancer Related Lymphedema Self-Care Scale Score

    The Breast Related Lymphedema Self-Care Scale is valid and reliable tool. The lowest score is 31, the highest score is 124. Higher scores indicate better self-care.

    baseline, 1 month, 3 month

  • Change in Quality of Life Measure for Limb Lymphedema-Arm Scale Score

    The Quality of Life Measure for Limb Lymphedema-Arm Scale was translated and cross-culturally adapted to Turkish. The highest score of the scale is 80 and the lowest score is 20. A high score indicates poor quality of life.

    baseline, 1 month, 3 month

  • Change in Lymphedema Symptom Intensity and Distress Survey Score

    The Turkish version of Lymphedema Symptom Intensity and Distress Survey is valid and reliable. The highest score of the scale is 30 and the lowest score is zero. A high score means experiencing too many symptoms.

    baseline, 1 month, 3 month

Secondary Outcomes (1)

  • Change in Arm circumferences

    baseline, 1 month, 3 month

Study Arms (2)

mobile programme users

EXPERIMENTAL

Patients will receive and use Mobile Lymphedema Self-Care Support Program application and will receive standart lymphedema education.

Other: Mobile Lymphedema Self-Care Support ProgramOther: standart lymphedema education

control group

ACTIVE COMPARATOR

Patients who will receive standart lymphedema education

Other: standart lymphedema education

Interventions

The Mobile Lymphedema Self-Care Support Program is composed of three section. First section includes the information about lymphedema and lymphedema self care. Second section includes the exercises videos which women can concurrently exercise with application and an alarm to remind to exercise. Last section is a social network form the women could chat and share anything with eachother. Patients will be told how to use the Mobile Lymphedema Self-Care Support Program and a contact number will be provided to ask questions about the program at any time.

Also known as: standard lymphedema education
mobile programme users

The control group will receive standard lymphedema education. The standard lymphedema education is an online education composed of information about lymphedema and lymphedema self-care.

control groupmobile programme users

Eligibility Criteria

Age20 Years - 55 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • diagnosed as breast cancer-related lymphedema
  • literate,
  • having a smart phone,
  • completed breast cancer treatment at least six months ago
  • volunteering to participate in the study

You may not qualify if:

  • having morbid obesity
  • having metastazis
  • having dementia
  • having other psychiatric conditions
  • another health problem that could prevent to exercise
  • not using smart phone

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ege Universitesi, Lymphedema unit of Physical therapy and rehabilitation department

Izmir, Bornova, 35030, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Breast Cancer Lymphedema

Condition Hierarchy (Ancestors)

LymphedemaLymphatic DiseasesHemic and Lymphatic DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Özgül Karayurt, PhD

    Izmir University of Economics

    STUDY CHAIR
  • Sibel Eyigör, MD

    Ege University

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
The patients were blinded and the person responsible for the data analysis will be masked as to the patient grouping for analysis.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: a prospective, randomized controlled study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 15, 2021

First Posted

September 27, 2021

Study Start

September 1, 2021

Primary Completion

December 1, 2021

Study Completion

December 1, 2021

Last Updated

February 20, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will not share

Locations